Buy & Sell Citius Pharmaceuticals Inc (CTXR) – Citius Pharmaceuticals Inc Price Today
Key Stats
- $16.56MMarket Cap
- HealthSector
- -45.1%3M Drawdown
- $12.78MEnterprise Value
- -Dividend Yield
- 49% Buy | 51% SellTrading Activity
- 8 daysTypical Hold Time
Citius Pharmaceuticals Inc (CTXR) is currently valued at a market capitalization of $16.56M, with an enterprise value of $12.78M. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.53 and a high of $2.21, highlighting its annual price range. Over the past three months, Citius Pharmaceuticals Inc has recorded a drawdown of -45.1%, reflecting recent price volatility. On average, investors hold Citius Pharmaceuticals Inc for approximately 8 days, indicating typical investor behavior on the platform.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
Wound irrigation systems market to grow to $430M by 2035, driven by rising chronic wounds and surgeries.
The global wound irrigation systems market, valued at $307.87 million in 2025, is projected to reach $430.05 million by 2035 with a CAGR of 3.55%. Growth is fueled by increasing chronic wound cases, more surgeries, and rising diabetes and obesity rat...

Mastercard appoints Ling Hai as CFO amid leadership reshuffle and faces weak stock momentum.
Mastercard announced a leadership reshuffle effective August 3, with Ling Hai, president of Asia Pacific, Europe, Middle East, and Africa, named as the new CFO, replacing Sachin Mehra who will become chief business officer. Other leadership changes i...

Goldman Sachs CEO says 'greed mode' is back as AI IPOs from OpenAI, SpaceX, Anthropic loom with strong liquidity.
Goldman Sachs CEO David Solomon stated that investors are in "greed mode" amid a wave of upcoming IPOs from major AI companies like OpenAI, SpaceX, and Anthropic. He emphasized that market liquidity is strong enough to support these large equity offe...
